Related Experiment Video
Updated: Jan 21, 2026

Loss-of-Function Approach in the Embryonic Chick Retina by Using Tol2 Transposon-Mediated Transgenic Expression of Artificial microRNAs
Published on: May 18, 2022
Corticolimbic analysis of microRNAs and protein expressions in scopolamine-induced memory loss under stress
Mehdi Eivani1, Sakineh Alijanpour2, Ehsan Arefian3
1Neuroscience Lab, Department of Animal Biology, School of Biology, College of Science, University of Tehran, Tehran, Iran.
Abstract:
The aim of the present study was to assess thealterations of corticolimbic microRNAs and protein expressions in the effect of scopolamine with or without stress on passive-avoidance memory in male Wistar rats. The expressions of miR-1, miR-10 and miR-26 and also the levels of p-CREB, CREB, C-FOS and BDNF in the prefrontal cortex (PFC), the hippocampus and the amygdala were evaluated using RT-qPCR and Western blotting techniques. The data showed that the administration of a muscarinic receptor antagonist, scopolamine or the exposure to 30 min stress significantly induced memory loss. Interestingly, the injection of an ineffective dose of scopolamine (0.5 mg/kg) alongside with exposure to an ineffective time of stress (10 min) impaired memory formation, suggesting a potentiative effect of stress on scopolamine response. Our results showed that memory formation was associated with the down-regulated expression of miR-1, miR-10 and miR-26 in the PFC and the hippocampus, but not the amygdala. The relative expression increase of miR-1 and miR-10 in the PFC and the hippocampus was shown in memory loss induced by scopolamine administration or 30-min stress. The PFC level of miR-10 and also hippocampal level of miR-1 and miR-10 were significantly up-regulated, while amygdala miR-1 and miR-26 were down-regulated in scopolamine-induced memory loss under stress. Memory formation increased BDNF, C-FOS and p-CREB/CREB in the PFC, the hippocampus and the amygdala. In contrast, the PFC, hippocampal and amygdala protein expressions were significantly decreased in memory loss induced by scopolamine administration (2 mg/kg), stress exposure (for 30 min) or scopolamine (0.5 mg/kg) plus stress (10 min). One of the most significant findings to emerge from this study is that the stress exposure potentiated the amnesic effect of scopolamine may via affecting the expressions of miRs and proteins in the PFC, the hippocampus and the amygdala. It is possible to hypothesis that corticolimbic signaling pathways play a critical role in relationship between stress and Alzheimer's disease.
Insights
Stress potentiates scopolamine-induced memory loss by altering microRNA and protein expressions in the brain. This study investigated these effects on passive-avoidance memory in rats, highlighting potential links to Alzheimer's disease.
Area of Science:
- Neuroscience
- Molecular Biology
- Pharmacology
Background:
- Scopolamine, a muscarinic receptor antagonist, is known to induce memory impairment.
- Stress is also implicated in cognitive deficits and memory loss.
- The interplay between scopolamine, stress, and memory at the molecular level, particularly involving microRNAs and proteins in corticolimbic regions, requires further investigation.
Purpose of the Study:
- To investigate the effects of scopolamine, stress, and their combination on passive-avoidance memory in male Wistar rats.
- To analyze the alterations in microRNA (miR-1, miR-10, miR-26) and protein (p-CREB, CREB, C-FOS, BDNF) expressions in the prefrontal cortex (PFC), hippocampus, and amygdala.
Main Methods:
- Administration of scopolamine and exposure to varying durations of stress.
- Evaluation of passive-avoidance memory performance.
- Quantification of microRNA and protein expressions using RT-qPCR and Western blotting techniques.
Main Results:
- Both scopolamine and stress significantly induced memory loss, with a potentiative effect observed when combined at lower doses/durations.
- Memory formation was associated with differential regulation of miR-1, miR-10, and miR-26 in the PFC and hippocampus.
- Scopolamine and stress significantly decreased the expression of BDNF, C-FOS, and p-CREB/CREB in the PFC, hippocampus, and amygdala.
Conclusions:
- Stress exposure potentiates the amnesic effects of scopolamine, likely by modulating microRNA and protein expressions in corticolimbic circuits.
- These findings suggest that corticolimbic signaling pathways are critical in the relationship between stress and memory impairment.
- The study provides a molecular basis for understanding how stress and pharmacological agents interact to affect memory, with implications for neurodegenerative diseases like Alzheimer's.
Related Concept Videos
MicroRNAs
MicroRNAs
Line Loss
Line loss impacts power delivery efficiency in a balanced three-phase circuit. The symmetry in such a circuit simplifies the...
Responses to Heat and Cold Stress
Reducing Line Loss
With a step-up transformer at the source, the voltage is increased, thereby reducing the current in the transmission lines since power loss in...
Design of Transmission Shafts - Stress Analysis

